Chemotherapy of malignant melanoma.
D000477:Alkylating Agents / Q000627:therapeutic use; D000577:Amides / Q000627:therapeutic use; D000818:Animals; D000937:Antigen-Antibody Reactions; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007111:Immunity, Cellular; D007167:Immunotherapy; D007664:Ketosteroids / Q000627:therapeutic use; D017710:Lymphocyte Transfusion; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology; D008558:Melphalan / Q000627:therapeutic use; D051379:Mice; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010477:Perfusion; D011283:Pregnenes / Q000627:therapeutic use; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D012737:Sex Factors; D012878:Skin Neoplasms / Q000188:drug therapy*; D014226:Triazenes / Q000627:therapeutic use*; D014611:Vaccination; D014748:Vinca Alkaloids / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage
D000477:Alkylating Agents; D000577:Amides; D000963:Antimetabolites; D000970:Antineoplastic Agents; D007093:Imidazoles; D007664:Ketosteroids; D009607:Nitrosourea Compounds; D011283:Pregnenes; D014226:Triazenes; D014748:Vinca Alkaloids; D011344:Procarbazine; D014750:Vincristine; D008558:Melphalan; D002330:Carmustine